89bio, Inc. (NASDAQ:ETNB – Get Free Report) saw a large increase in short interest during the month of June. As of June 30th, there was short interest totalling 9,500,000 shares, an increase of 36.5% from the June 15th total of 6,960,000 shares. Based on an average daily trading volume, of 1,450,000 shares, the days-to-cover ratio […]
Endurant Capital Management LP purchased a new stake in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 17,886 shares of the biopharmaceutical company’s stock, valued at approximately $683,000. Other hedge funds have also added to […]
Endurant Capital Management LP acquired a new position in shares of Healthpeak Properties, Inc. (NYSE:PEAK – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 59,578 shares of the company’s stock, valued at approximately $1,494,000. A number […]
Endurant Capital Management LP acquired a new position in shares of Elevance Health, Inc. (NYSE:ELV – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 26,077 shares of the company’s stock, valued at approximately $13,377,000. Elevance Health […]
Endurant Capital Management LP purchased a new position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 4,596 shares of the biopharmaceutical company’s stock, valued at approximately $1,092,000. A number of […]